MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0161096
Medpace Clinical Research India Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹19.34 Cr
▲ 36% YoY
Net profit · FY 2025
₹72.31 Lakh
Net margin 3.7%
EBITDA · FY 2025
₹4.12 Cr
EBITDA margin 21.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
19 yrs
Est. 2007
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Medpace Clinical Research India Private Limited
Data last updated:
Medpace Clinical Research India Private Limited is a private limited company based in Thane, Maharashtra, India, a subsidiary of Medpace Holding Company, Inc.. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 07 March 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24232MH2007PTC338993. Its GSTIN is 27AACCN4714H1ZK (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Jesse Jacob Geiger and Stephen Paul Ewald.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No. 1203 12th Floor Building Q2 Aurum Q Park, Ttc Industrial Area Thane – Belapur Road Ghansoli, Maharashtra, India – 400710.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.34 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹72.31 Lakh (net margin 3.7%) and EBITDA of ₹4.12 Cr (EBITDA margin 21.3%). Revenue has grown at a compounded annual rate (CAGR) of 48% over three years and 33% over five years.
The company is associated with 1 brand: Medpace.
Medpace Clinical Research India Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0161096). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medpace.com.
Company details
CIN U24232MH2007PTC338993
Registration Number 338993
Incorporation Date 07 March 2007
ROC Mumbai
Listing Status Unlisted
Company Status Active
Parent Company Medpace Holding Company, Inc.
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0161096
CIN history
Medpace Clinical Research India has one previous CIN (Corporate Identification Number): U24232DL2007PTC160227. The current CIN is U24232MH2007PTC338993, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232MH2007PTC338993 | Current |
| U24232DL2007PTC160227 | Previous |
Recognitions & Rankings of Medpace Clinical Research India
Contact details
Medpace Clinical Research India Private Limited's registered office is in Thane, Maharashtra. Its website is medpace.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressUnit No. 1203 12th Floor Building Q2 Aurum Q Park, Ttc Industrial Area Thane – Belapur Road Ghansoli, Maharashtra, India – 400710
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Medpace Clinical Research India Private Limited, buy the company report.
Comprehensive company report
Medpace Clinical Research India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Medpace Clinical Research India operates one associated brand: Medpace. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A range of clinical research services is offered by Medpace. | medpace.com |
Business activity
The main business activity of Medpace Clinical Research India is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Medpace Clinical Research India Private Limited, buy the company report.
Financials of Medpace Clinical Research India Private Limited
FY 2025 filings availableMedpace Clinical Research India Private Limited reported revenue of ₹19.34 Cr (up 36% YoY) for FY 2025.
Revenue · FY 2025
₹19.34 Cr ▲ 36%
Net profit · FY 2025
₹72.31 Lakh margin 3.7%
EBITDA · FY 2025
₹4.12 Cr margin 21.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 36%
3 years · compounded
▲ 48%
5 years · compounded
▲ 33%
EBITDA CAGR growth
1 year
▲ 38%
3 years · compounded
▲ 71%
5 years · compounded
▲ 49%
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years, including 36% growth in the latest year. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.12 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹72.31 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.3% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medpace Clinical Research India Private Limited, buy the company report.
Board of directors of Medpace Clinical Research India Private Limited
Medpace Clinical Research India has 3 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jesse Jacob Geiger | Director | 16 Nov 2020 | 5 Years 11 Months | Current |
| Stephen Paul Ewald | Director | 16 Nov 2020 | 5 Years 11 Months | Current |
| Preeti Kabra Also directs: Tatva Techno Ventures LLP | Director | 26 Apr 2023 | 3 Years 6 Months | Current |
Peer comparison
Medpace Clinical Research India Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medpace Clinical Research India Private Limitedthis company | ₹19.34 Cr (FY 2025) | ₹72.31 Lakh | 3.7% | 36.0% | Thane, Maharashtra, India | |
| G7 Synergon Private Limited | ₹18.97 Cr (FY 2025) | 73.0% | Bangalore, Karnataka, India | |||
| Cod Research Private Limited | ₹18.93 Cr (FY 2024) | 244.0% | Ahmedabad, Gujarat, India | |||
| Sci-Tech Centre | ₹18.62 Cr (FY 2025) | -38.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Medpace Clinical Research India Private Limited, buy the company report.
Auditor
Medpace Clinical Research India Private Limited is audited by SUDIT K. PAREKH & CO. LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUDIT K. PAREKH & CO. LLP | FY 2023 | 110512W/W100378 |
Shareholding
The shareholding of Medpace Clinical Research India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medpace Clinical Research India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medpace Clinical Research India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Medpace Clinical Research India Private Limited has 4 MSME Form 1 returns on record between 2020 and 2022, listing 8 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| The Registar Kle University | |||
| Aashiyana Enterprises | |||
| Shubhalaxmi Stationery & Xerox | |||
| Sudit K. Parekh & Co. LLP |
To see the full MSME payment records of Medpace Clinical Research India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Medpace Clinical Research India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCN4714H1ZK | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medpace Clinical Research India Private Limited, buy the company report.
Recent activity
Medpace Clinical Research India Private Limited has 13 board changes on record since 2010: 3 appointments and 10 cessations. The latest: Samir Shankar Dalvi ceased to be Additional Director on 29 Sep 2023.
AGM
Medpace Clinical Research India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medpace Clinical Research India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Ceased
Samir Shankar Dalvi ceased to be Additional Director.
Appointed
Preeti Kabra was appointed as Director.
Ceased
Jesse Jacob Geiger ceased to be Additional Director.
Ceased
Stephen Paul Ewald ceased to be Additional Director.
Ceased
August James Troendle ceased to be Director.
Appointed
Jesse Jacob Geiger was appointed as Director.
Appointed
Stephen Paul Ewald was appointed as Director.
Ceased
Susan Elizabeth Burwig ceased to be Director.
Ceased
Chandrashekhar Puranik Narhar ceased to be Additional Director.
Ceased
Preeti Kabra ceased to be Director.
4 earlier events are in the company report.
News
Frequently asked questions
Medpace Clinical Research India is an active private limited company based in Thane, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 07 March 2007 (19+ years old) and is registered under CIN U24232MH2007PTC338993.
Medpace Clinical Research India has 3 current directors:
- Jesse Jacob Geiger - Director
- Stephen Paul Ewald - Director
- Preeti Kabra - Director
The latest financial statements of Medpace Clinical Research India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Medpace Clinical Research India is 27AACCN4714H1ZK, registered in Maharashtra.
The CIN (Corporate Identification Number) of Medpace Clinical Research India is U24232MH2007PTC338993. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medpace Clinical Research India was incorporated on 07 March 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Medpace Clinical Research India by revenue are G7 Synergon Private Limited, Cod Research Private Limited, Sci-Tech Centre, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Samir Shankar Dalvi ceased to be Additional Director on 29 Sep 2023. Preeti Kabra was appointed as Director on 26 Apr 2023. Jesse Jacob Geiger ceased to be Additional Director on 21 Dec 2020. Medpace Clinical Research India has 13 board changes on record in total.
Yes, Medpace Clinical Research India is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0161096).
Medpace Clinical Research India has 4 MSME Form 1 returns on record between 2020 and 2022, listing 8 overdue payments to 4 micro and small suppliers. The latest return was filed on 26 Apr 2022.
Medpace Clinical Research India can be reached through the website medpace.com. Its registered office is in Thane, Maharashtra, India.
The registered office of Medpace Clinical Research India is at Unit No. 1203 12th Floor Building Q2 Aurum Q Park, Ttc Industrial Area Thane – Belapur Road Ghansoli, Maharashtra, India – 400710.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages